Avestria Ventures, a San Francisco, CA-based venture capital firm focused on women’s health and female-led life sciences companies, closed its first fund, Avestria Ventures Fund I.
Founded in 2019 by veteran life science industry executives Linda Greub and Corinne Nevinny, Avestria invests in early-stage women’s health companies and female-led life science ventures that have products or services which address unmet needs, improve healthcare quality and/or access, maintain or lower costs, and induce clinical or behavioral change.
Avestria closed Fund I to new investors due to the June 16th acquisition of its portfolio company Alydia Health for up to $240M by Organon (NYSE: OGN), a global women’s health company. Uqora, a second Avestria portfolio company, was acquired on July 1st by Pharmavite for an undisclosed amount.
FinSMEs
27/08/2021